SCHEMBL2967574

SCHEMBL2967574

Clc1cccc2c(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c3cccc(Cl)c3cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.44
CYP1A2 P05177 4/20 0.44
DYRK1A Q13627 1/20 0.38
SMO Q99835 1/20 0.37
ESR2 Q92731 2/20 0.37
MAP2 P11137 1/20 0.36
NR4A2 P43354 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
ESR1 P03372 1/20 0.35
RHEB Q15382 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
RORB Q92753 1/20 0.34
DHODH Q02127 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22512513 0.90 CYP2A6 (0.50) CYP2A6CYP1A2DYRK1AESR2MAP2
SCHEMBL29373135 0.83 ALDH1A1 (0.50) CYP1A2ESR2ESR1ALDH1A1LMNA
SCHEMBL261400 0.83 ALDH1A1 (0.50) CYP1A2ESR2ESR1ALDH1A1LMNA
SCHEMBL30708996 0.82 RXRA (0.46) CYP1A2ESR2ESR1TSHRKMO
SCHEMBL30709030 0.82 CYP1A2 (0.46) CYP1A2ESR2MAP2ESR1ALDH1A1
SCHEMBL23702367 0.81 ALDH1A1 (0.47) ESR2ESR1ALDH1A1LMNAKMT2A
SCHEMBL2965154 0.81 ALDH1A1 (0.47) CYP1A2ESR2ESR1ALDH1A1LMNA
SCHEMBL28326311 0.79 CYP1A2 (0.52) CYP2A6CYP1A2DYRK1AESR2MAP2
SCHEMBL2087807 0.78 CYP1A2 (0.60) CYP1A2ESR2ESR1ALDH1A1LMNA
SCHEMBL7900244 0.77 MAOA (0.44) ESR2ESR1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same JNC CORPORATION (JP) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100025661-A1 Luminescent material and organic electroluminescent device using the same TRPV3, TRPC3, HVCN1 CYP2A6 2970/4885CYP1A2 1391/4885DYRK1A 4052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.